Dr. Manabu Fujita, MD, PhD

Dr. Fujita practices at Los Robles Regional Medical Center in Thousand Oaks, California, part of HCA Healthcare.

Dr. Fujita's NPI, 1174888937, was assigned on July 9, 2012. Dr. Fujita holds California license A110892.

Dr. Fujita's primary practice is Los Robles Regional Medical Center, at 215 W Janss Rd, Thousand Oaks, CA 91360 in Ventura County. The practice phone is (805) 497-2727.

Dr. Fujita's primary practice is Los Robles Regional Medical Center in Thousand Oaks, California, part of HCA Healthcare. The medical group on file is UCLA Associated General Surgeons. Dr. Fujita's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fujita practices. Vendor and product names are available with a free account.

Surgical oncology is Dr. Fujita's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Fujita is board certified in complex general surgical oncology by the American Board of Surgery. Dr. Fujita is licensed in California.

Dmand AI lists abdominal adhesion surgery, abdominal hernia repair surgery, acute gallbladder or bile duct inflammation, appendectomy, breast reconstruction, cancerous skin growth removal, colon removal and esophagus, stomach, or upper small intestine surgery among the conditions Dr. Fujita treats.

CMS data shows 491 Medicare services from Dr. Fujita across 10 procedure codes in 2024, for 290 Medicare patients. Medicare paid $87,723 for them.

CMS counts 290 Medicare patients who saw Dr. Fujita in 2024. The largest group is 75 to 84, with 116 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fujita's median patient age at 64, with 51% women.

In 2024, Dr. Fujita wrote 115 Medicare Part D claims for 66 patients. 91% of them were for generic drugs. CMS names the drug for 48 of them, across 2 drugs with 11 or more claims each, at $286 in total drug cost. In 2023, CMS named 47 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 19 out of 100 for Dr. Fujita for performance year 2024, reported individually. Dr. Fujita accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of hernia repair - groin (open) by Dr. Fujita, more than 92% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Fujita, published from 2006 to 2024. 2006 was the busiest year, with 2. The most frequent topics are Malates, Polymers and Laminin. Dr. Fujita's most frequent co-authors are Keith Lanier Black, MD, Anton J. Bilchik, MBA, MD, PhD and Tamir Eliyahu Bresler, MD.

CMS Open Payments shows 33 general payments to Dr. Fujita from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Intuitive Surgical, Inc. paid the most, $1,137.

Dr. Fujita is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.